Showing 321-330 of 3974 results for "".
Stirring the Pot: Cannabinoids and Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/stirring-the-pot-cannabinoids-and-atopic-dermatitis/20565/Cannabinoids are a diverse group of compounds that may hold significant therapeutic capabilities applicable to many areas of medicine, including dermatology.Take 5: Promising Therapies for Rosacea
https://practicaldermatology.com/columns/take-5/take-5-promising-therapies-for-rosacea/21716/Five new studies offer insights for treating and understanding rosacea.Vitamin D and Psoriasis
https://practicaldermatology.com/topics/practice-management/vitamin-d-and-psoriasis/21470/New findings suggest a relationship between psoriasis and vitamin D deficiency, but larger details are still unknown."Psleep": Psoriasis and Sleep
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/psleep-psoriasis-and-sleep/29075/The “invisible” impacts of psoriasis are those not directly seen on examination. These include itch, pain, fatigue and sleep dysfunction, which may be improved by our systemic therapies. However, there is a gap between the patients’ reporting of these experienced invisible impacts and their physiciaGLP-1 Receptor Agonists: Current Roles in Medicine
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-current-roles-in-medicine/48897/In recent years, the popularity of glucagon-like peptide 1 receptor agonists (GLP-1RAs) has skyrocketed, along with interest in clinical applications beyond diabetes and weight management. Here, we present a brief review of GLP-1RAs, including a history, a look at the mechanism of action, pivotal reAlternative Therapies for the Treatment of Acne
https://practicaldermatology.com/topics/acne-rosacea/alternative-therapies-for-the-treatment-of-acne/23787/Many patients are interested in alternative options instead of or alongside prescription acne treatments.Pipeline and Potential Roles for GLP-1RAs in Dermatology
https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/Having reviewed the mechanism of action and current roles in medicine for glucagon-like peptide 1 receptor agonists (GLP-1RAs), we now can discuss therapies in this class currently under investigation for management of dermatologic disease.A Multidisciplinary Toolbox for Atopic Dermatitis Treatments
https://practicaldermatology.com/topics/atopic-dermatitis/a-multidisciplinary-toolbox-for-atopic-dermatitis-treatments/23445/Clinical Updates on Psoriasis Management
https://practicaldermatology.com/topics/psoriasis/clinical-updates-on-psoriasis-management/21496/Dupilumab For the Management of Pembrolizumab-induced Rash: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dupilumab-for-the-management-of-pembrolizumab-induced-rash-a-case-report/23841/